PRAXBIND Trademark

Trademark Overview

On Friday, June 26, 2015, a trademark application was filed for PRAXBIND with the United States Patent and Trademark Office. The USPTO has given the PRAXBIND trademark a serial number of 79171941. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, December 9, 2022. This trademark is owned by Boehringer Ingelheim International GmbH. The PRAXBIND trademark is filed in the Pharmaceutical Products category with the following description:

[ Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of hormonal, infectious, viral and oncological diseases and disorders ] * Pharmaceutical preparations for the treatment of cardiovascular disease, namely, antihemorrhagic agent *
praxbind

General Information

Serial Number79171941
Word MarkPRAXBIND
Filing DateFriday, June 26, 2015
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, December 9, 2022
Registration Number4938928
Registration DateTuesday, April 19, 2016
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 2, 2016

Trademark Statements

Description of MarkThe mark consists of the stylized wording "PRAXBIND" with two semi-circular curved arrow designs, with one appearing beneath the lettering "BIND" and the other wrapped from the right edge of the lettering "BIND" and continuing above said lettering.
Amendment to a Registration/Renewal CertificateIn the statement, Column 1," lines 5-12" is deleted, and Pharmaceutical preparations for the treatment of cardiovascular disease, namely antihemorrhagic agent is inserted.
Goods and Services[ Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of hormonal, infectious, viral and oncological diseases and disorders ] * Pharmaceutical preparations for the treatment of cardiovascular disease, namely, antihemorrhagic agent *
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 10, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address55216 Ingelheim
DE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address55216 Ingelheim
DE

Trademark Events

Event DateEvent Description
Thursday, September 3, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, September 9, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, September 15, 2015APPLICATION FILING RECEIPT MAILED
Thursday, September 10, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 28, 2015ASSIGNED TO EXAMINER
Tuesday, October 6, 2015NON-FINAL ACTION WRITTEN
Thursday, October 8, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, October 29, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 8, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 8, 2015AMENDMENT FROM APPLICANT ENTERED
Wednesday, October 7, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 8, 2015REFUSAL PROCESSED BY MPU
Saturday, October 24, 2015REFUSAL PROCESSED BY IB
Thursday, November 12, 2015PAPER RECEIVED
Monday, November 30, 2015ASSIGNED TO LIE
Tuesday, December 29, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 27, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 10, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Saturday, February 13, 2016NOTIFICATION PROCESSED BY IB
Tuesday, December 8, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 16, 2015ASSIGNED TO LIE
Wednesday, January 27, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, February 2, 2016PUBLISHED FOR OPPOSITION
Tuesday, February 2, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, August 5, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 19, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, February 18, 2016ASSIGNED TO PETITION STAFF
Monday, February 22, 2016POST PUBLICATION AMENDMENT - ENTERED
Friday, March 11, 2016CORRECTION TRANSACTION RECEIVED FROM IB
Friday, April 15, 2016CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Tuesday, April 19, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, July 19, 2016FINAL DISPOSITION PROCESSED
Tuesday, July 19, 2016FINAL DISPOSITION NOTICE SENT TO IB
Monday, January 24, 2022TEAS SECTION 71 & 15 RECEIVED
Sunday, June 26, 2022POST REGISTRATION ACTION MAILED - SEC. 7
Thursday, December 8, 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, January 27, 2022TEAS SECTION 7 REQUEST RECEIVED
Thursday, June 23, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 9, 2022AMENDMENT UNDER SECTION 7 - PROCESSED
Friday, December 9, 2022REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Friday, December 9, 2022NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Tuesday, January 17, 2023NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Thursday, April 10, 2025INTERNATIONAL REGISTRATION RENEWED
Saturday, May 31, 2025CORRECTION TRANSACTION RECEIVED FROM IB
Saturday, April 19, 2025COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

Related Keywords

praxbind system preparations pharmaceutical treatment disorders diseases namely blood nervous cardiovascular